![Shlomo Yanai, incoming president and CEO of Teva Pharmaceutical Industries, Ltd., takes part in the opening bell ceremonies at the NASDAQ in New York on February 21, 2007. (UPI Photo/Laura Cavanaugh Stock Shlomo Yanai, incoming president and CEO of Teva Pharmaceutical Industries, Ltd., takes part in the opening bell ceremonies at the NASDAQ in New York on February 21, 2007. (UPI Photo/Laura Cavanaugh Stock](https://c8.alamy.com/comp/TYHXYC/shlomo-yanai-incoming-president-and-ceo-of-teva-pharmaceutical-industries-ltd-takes-part-in-the-opening-bell-ceremonies-at-the-nasdaq-in-new-york-on-february-21-2007-upi-photolaura-cavanaugh-TYHXYC.jpg)
Shlomo Yanai, incoming president and CEO of Teva Pharmaceutical Industries, Ltd., takes part in the opening bell ceremonies at the NASDAQ in New York on February 21, 2007. (UPI Photo/Laura Cavanaugh Stock
![From left, Dan S. Suesskind, CFO, Shlomo Yanai, incoming president and CEO, Israel Makov, outgoing president and CEO, and Eli Hurvitz, chairman of the board of Teva Pharmaceutical Industries, Ltd. take part From left, Dan S. Suesskind, CFO, Shlomo Yanai, incoming president and CEO, Israel Makov, outgoing president and CEO, and Eli Hurvitz, chairman of the board of Teva Pharmaceutical Industries, Ltd. take part](https://c8.alamy.com/comp/TYHXY9/from-left-dan-s-suesskind-cfo-shlomo-yanai-incoming-president-and-ceo-israel-makov-outgoing-president-and-ceo-and-eli-hurvitz-chairman-of-the-board-of-teva-pharmaceutical-industries-ltd-take-part-in-the-opening-bell-ceremonies-at-the-nasdaq-in-new-york-on-february-21-2007-upi-photolaura-cavanaugh-TYHXY9.jpg)
From left, Dan S. Suesskind, CFO, Shlomo Yanai, incoming president and CEO, Israel Makov, outgoing president and CEO, and Eli Hurvitz, chairman of the board of Teva Pharmaceutical Industries, Ltd. take part
![Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product | Markets Insider Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product | Markets Insider](https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2023/01/23/cprx_logo_light__82963f5650c4da573ca4d8c38d44df2f.png)
Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product | Markets Insider
![From left, Dan S. Suesskind, CFO, Shlomo Yanai, incoming president and CEO, Israel Makov, outgoing president and CEO, and Eli Hurvitz, chairman of the board of Teva Pharmaceutical Industries, Ltd. take part in the opening bell ceremonies at the ... From left, Dan S. Suesskind, CFO, Shlomo Yanai, incoming president and CEO, Israel Makov, outgoing president and CEO, and Eli Hurvitz, chairman of the board of Teva Pharmaceutical Industries, Ltd. take part in the opening bell ceremonies at the ...](https://c8.alamy.com/comp/TYHXY6/from-left-dan-s-suesskind-cfo-shlomo-yanai-incoming-president-and-ceo-israel-makov-outgoing-president-and-ceo-and-eli-hurvitz-chairman-of-the-board-of-teva-pharmaceutical-industries-ltd-take-part-in-the-opening-bell-ceremonies-at-the-nasdaq-in-new-york-on-february-21-2007-upi-photolaura-cavanaugh-TYHXY6.jpg)